Biogen (BIIB) has an average rating of overweight and mean price target of $224.10, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $191.24, Change: $-17.80, Percent Change: -8.51%